A resource-efficient granulation process for advanced formulation of any compound in food and pharma production

Projektinformationen

AGS

ID Finanzhilfevereinbarung: 703309

DOI 10.3030/703309

Projekt abgeschlossen

EK-Unterschriftsdatum 17 Dezember 2015

Startdatum 1 Dezember 2015

Enddatum 31 März 2016

Finanziert unter

• SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

POLIBIOTECH SRL
Italy

Ziel

Polibiotech, an SME from Italy, has developed a patented advanced manufacturing process that successfully formulates any chemical compound quicker, at a lower cost and resource-efficiently. Current chemicals production procedures of wet and dry granulation have difficulties with universality, waste ingredients and energy consumption. Nutraceutical formulation requires repetitive research and testing to prove viability and is an extremely inefficient, time-consuming process (lasting up to several months). The Aerodynamic Granulation System (AGS) is a new process of dry granulation that revolutionises the formulation process and successfully manufactures any drug. The system uses a gas flow to optimise particle transportation and granule separation. The system is eco-sustainable as less raw materials are input and waste can be recycled through the use of a continuous process in a closed system. The AGS method reduces formulation time from several months to one day. At peak performance the AGS could produce more than one new formulation per week and a basic machine would have capacity to produce 1 tonne a day. The system concept will initially be applied to the nutraceutical markets; however, any product that requires the combination of chemicals to form a homogeneous compound can utilize this technique including the pharmaceutical market. An advanced prototype AGS has been constructed and trialled in an operational environment and a variety of products have been formulated. Within the overall project Polibiotech intend to: construct a second pilot plant in Italy; engineer a series of online quality control tests; validate the full scale AGS line for the production of nutraceutical compounds and gain certification for manufacturing roll out within the EU.

Wissenschaftliches Gebiet

• engineering and technology › mechanical engineering › manufacturing engineering
• engineering and technology › environmental engineering › waste management
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › sensors
• natural sciences › mathematics › pure mathematics › geometry
• social sciences › economics and business › business and management › employment

Programm/Programme

• H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• SFS-08-2015-1 - Resource-efficient eco-innovative food production and processing

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2015

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

POLIBIOTECH SRL

• Netto-EU-Beitrag: € 50 000,00
• Adresse: VIA ALBANO 77 SCALA D PIANO 6 ; 00179 Rome ; Italien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Centro (IT) › Lazio › Roma
• Region: Centro (IT) › Lazio › Roma
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00

Beteiligte (2)

CO.RA. SRL

Italien

• Netto-EU-Beitrag: € 0,00
• Adresse: LOC. CHIAPPINI, 51 ; 55011 Spianate - Altopascio, Lucca
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Centro (IT) › Toscana › Lucca
• Region: Centro (IT) › Toscana › Lucca
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: Keine Daten

PHARMIA OY

Finnland

• Netto-EU-Beitrag: € 0,00
• Adresse: KALLIOTIE 2 ; 04360 TUUSULA
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Manner-Suomi › Helsinki-Uusimaa › Helsinki-Uusimaa
• Region: Manner-Suomi › Helsinki-Uusimaa › Helsinki-Uusimaa
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: Keine Daten